No detection of  SARS-CoV-2 in cystic fibrosis patients at the Regional (Lazio) Reference Center for CF in Italy

The newly emergent human coronavirus (HCoV), known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a worldwide threat and the most severe public healthcare concern. The impact of SARS-CoV-2 on cystic fibrosis (CF) remains poorly understood, still there are serious concerns over its potential effect due to deficiencies in respiratory tract physiology of CF patients that prevent efficient clearance of pathogens from the airways. SARS-CoV-2 infections have been observed in few CF patients and were associated to a not severe infection [1].

Source: Journal of Cystic Fibrosis - June 22, 2020 Category: Respiratory Medicine Authors: Carolina Scagnolari, Camilla Bitossi, Federica Frasca, Agnese Viscido, Giuseppe Oliveto, Mirko Scordio, Corrado De Vito, Maria Trancassini, Fabio Midulla, Giuseppe Cimino, Alessandra Pierangeli, Guido Antonelli Source Type: research